Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration Small Mol Conc Unit Replicate Seeding Density Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value
Hs 578T Nilotinib
19.9526
uM
1 156.25 76.08 2333.00 204.00 11.4363 10.0860
BT-20 Nilotinib
19.9526
uM
3 156.25 49.48 1254.00 100.00 12.5400 23.1536
SK-BR-3 Nilotinib
19.9526
uM
5 156.25 28.48 1122.00 89.00 12.6067 8.3441
BT-20 Nilotinib
19.9526
uM
4 156.25 44.67 1018.00 79.25 12.8454 42.7898
SK-BR-3 Nilotinib
19.9526
uM
4 312.50 180.13 3206.00 243.75 13.1528 732.1829
MCF7 Nilotinib
19.9526
uM
1 312.50 97.17 3084.00 212.25 14.5300 20.4838
MCF7 Nilotinib
19.9526
uM
1 312.50 97.17 3968.00 259.00 15.3205 12.7728
Hs 578T Nilotinib
19.9526
uM
1 156.25 76.08 3048.00 185.75 16.4092 16.5644
MDA-MB-231 Nilotinib
19.9526
uM
11 156.25 67.09 1886.00 112.50 16.7644 86.6766
SK-BR-3 Nilotinib
19.9526
uM
3 156.25 80.34 1297.00 74.50 17.4094 -1.0000
SK-BR-3 Nilotinib
19.9526
uM
3 156.25 80.34 1787.00 86.25 20.7188 14583671390700.0000
SK-BR-3 Nilotinib
19.9526
uM
4 156.25 63.10 1667.00 76.25 21.8623 161547.6102
Hs 578T Nilotinib
19.9526
uM
10 156.25 66.59 2112.00 96.50 21.8860 637.3529
SK-BR-3 Nilotinib
19.9526
uM
4 156.25 63.10 1747.00 67.75 25.7860 118181697914000.0000
MCF7 Nilotinib
19.9526
uM
1 156.25 31.46 3077.00 105.00 29.3048 12.9522
BT-20 Nilotinib
19.9526
uM
4 156.25 44.67 2680.00 75.00 35.7333 237.8839
SK-BR-3 Nilotinib
19.9526
uM
4 156.25 63.10 2890.00 76.75 37.6547 759459.5199
MCF7 Nilotinib
19.9526
uM
1 156.25 31.46 3456.00 84.75 40.7788 25.7539
BT-20 Nilotinib
19.9526
uM
4 156.25 44.67 2857.00 68.00 42.0147 950.5353
MCF7 Nilotinib
19.9526
uM
1 156.25 31.46 3974.00 67.75 58.6568 78.2039